Veterinary services provider CVS group has posted adjusted ebitda slightly ahead of expectations, causing Peel Hunt analysts to boost earnings per share for 2022 by three per cent. Vets were "relatively insulated from a consumer downturn" due to it being an essential service for pet owners, analysts added. They recommend a Buy rating, with a target price 2,750p.
Estate agent
(c) 2022 City A.M., source